Serological markers and Post COVID-19 Condition (PCC) – A rapid review of the evidence
View ORCID ProfileErin Collins, Elizabeth Philippe, View ORCID ProfileChris Gravel, View ORCID ProfileSteven Hawken, View ORCID ProfileMarc-André Langlois, View ORCID ProfileJulian Little
doi: https://doi.org/10.1101/2023.10.30.23297455
Erin Collins
1School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada
Elizabeth Philippe
1School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada
Chris Gravel
1School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada
2Department of Mathematics and Statistics, University of Ottawa
3Department of Epidemiology, Biostatistics and Occupational Health, McGill University
Steven Hawken
1School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada
4Clinical Epidemiology, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada
Marc-André Langlois
5Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Ontario Canada
6Coronavirus Variants Rapid Response Network (CoVaRR-Net), Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada
7Centre for Infection, Immunity and Inflammation (CI3), University of Ottawa, Ottawa, Ontario, Canada
Julian Little
1School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada
4Clinical Epidemiology, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada
6Coronavirus Variants Rapid Response Network (CoVaRR-Net), Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada
8The Knowledge Synthesis and Application Unit (KSAU), University of Ottawa, Ottawa, Ontario, Canada
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data availability
All relevant data are within the manuscript. No additional source data are required.
Posted October 30, 2023.
Serological markers and Post COVID-19 Condition (PCC) – A rapid review of the evidence
Erin Collins, Elizabeth Philippe, Chris Gravel, Steven Hawken, Marc-André Langlois, Julian Little
medRxiv 2023.10.30.23297455; doi: https://doi.org/10.1101/2023.10.30.23297455
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (668)
- Anesthesia (181)
- Cardiovascular Medicine (2649)
- Dermatology (223)
- Emergency Medicine (399)
- Epidemiology (12229)
- Forensic Medicine (10)
- Gastroenterology (760)
- Genetic and Genomic Medicine (4104)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2658)
- Health Policy (1005)
- Hematology (363)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (438)
- Neurology (3884)
- Nursing (209)
- Nutrition (578)
- Oncology (2033)
- Ophthalmology (585)
- Orthopedics (241)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1115)
- Primary Care Research (452)
- Public and Global Health (6530)
- Radiology and Imaging (1405)
- Respiratory Medicine (871)
- Rheumatology (410)
- Sports Medicine (343)
- Surgery (448)
- Toxicology (53)
- Transplantation (185)
- Urology (165)